Table 3.
Subgroups | No. of studies | No. of patients | OR and P value for mortality of different symptoms | ||||
---|---|---|---|---|---|---|---|
GI symptom | I 2 for GI symptom | Diarrhea | Nausea/vomiting | Abdominal pain | |||
1. Study location | |||||||
1.1 Asia | 28 | 39,501 (72%) | 1.43, P=0.01 | 54.7% | 1.32, P=0.21 | 1.3, P=0.36 | 1.07, P=0.85 |
Sub-subgroups for studies in Asia: | |||||||
1.1.1 GI group older than non-GI group | 7 | 32,894 | 2.43, P<0.01 | 66.9% | |||
1.1.2 GI group younger than non-GI group | 6 | 3048 | 1.2, P=0.29 | 15.8% | |||
1.2 America | 12 | 8324 (15%) | 0.64, P<0.01 | 42.7% | 0.81, P=0.37 | 0.84, P=0.8 | NA |
Sub-subgroups for studies in America: | |||||||
1.2.1 GI group older than non-GI group | NA | NA | NA | NA | |||
1.2.2 GI group younger than non-GI group | 5 | 3990 | 0.55, P<0.01 | 30.6% | |||
1.3 Europe | 10 | 2653 (5%) | 0.4, P<0.01 | 77% | 0.51, P=0.07 | 0.7, P=0.51 | 0.61, P=0.76 |
Sub-subgroups for studies in Europe: | |||||||
1.3.1 GI group older than non-GI group | NA | NA | NA | NA | |||
1.3.2 GI group younger than non-GI group | 3 | 805 | 0.23, P<0.01 | 84% | |||
1.4 Other | 3 | 4767(8%) | 0.92, P=0.83 | 87.8% | 0.93, P=0.92 | NA | NA |
2. Only include critically ill patients? | |||||||
3.1 Yes | 6 | 1124(2%) | 1.42, P=0.36 | 74.6% | 1.3, P=0.45 | 0.92, P=0.71 | 0.75, P=0.45 |
3.2 No | 47 | 54,121 (98%) | 0.83, P=0.1 | 78.3% | 0.92, P=0.69 | 1.37, P=0.28 | 2.67, P=0.05 |
3. Population size | |||||||
4.1 <500 | 36 | 7436 (13%) | 0.93, P=0.66 | 72.1% | 1.05, P=0.82 | 1.19, P=0.51 | 1.04, P=0.92 |
4.2 >=500 | 17 | 47,809 (87%) | 0.84, P=0.25 | 85.7% | 0.94, P=0.83 | 1.16, P=0.68 | NA |
4. Average age of GI group and non-GI group | |||||||
4.1 GI group older than non-GI group | 8 | 33,294 (60%) | 1.89, P=0.02 | 69% | |||
4.2 GI group younger than non-GI group | 14 | 7843 (14%) | 0.61, P=0.01 | 80% | |||
4.3 Unknown | 31 | 14,058 (26%) | 0.89, P=0.36 | 64% |
OR, odds ratio; GI, gastrointestinal; NA, not available